EP1358938A1 - Collection assembly - Google Patents
Collection assembly Download PDFInfo
- Publication number
- EP1358938A1 EP1358938A1 EP02023734A EP02023734A EP1358938A1 EP 1358938 A1 EP1358938 A1 EP 1358938A1 EP 02023734 A EP02023734 A EP 02023734A EP 02023734 A EP02023734 A EP 02023734A EP 1358938 A1 EP1358938 A1 EP 1358938A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- container
- liquid
- film
- tube
- moisture barrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/505—Containers for the purpose of retaining a material to be analysed, e.g. test tubes flexible containers not provided for above
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5082—Test tubes per se
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D77/00—Packages formed by enclosing articles or materials in preformed containers, e.g. boxes, cartons, sacks or bags
- B65D77/003—Articles enclosed in rigid or semi-rigid containers, the whole being wrapped
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/14—Process control and prevention of errors
- B01L2200/142—Preventing evaporation
Definitions
- the subject invention relates to plastic tubes that have been prefilled with controlled volumes and concentrations of liquid, and that are packaged to retain the liquid volume and concentration during storage.
- Drugs that are administered intravenously must be in a liquid form.
- the liquid must be of known volume and concentration to ensure proper dosage.
- Some drugs can be stored for considerable periods of time in a liquid form. Other drugs, however, must be stored in a powdered form, and then must be mixed with a specified volume of a liquid additive shortly prior to administration to the patient. Efficiencies can be achieved if the specified volume of the liquid drug and/or the specified volume of the liquid additive is available in a prefilled tube or other such container. Prefilled containers avoid the need for careful volummetric measuring immediately prior to administering the drug, and hence minimize the chance for error.
- Plastic tubes and other plastic containers are lightweight, relatively inexpensive and relatively unbreakable. As a result, plastic tubes are used for medical applications whenever possible. However, plastic tubes have an inherent permeability to water and other liquids. This high liquid permeability of plastics can significantly affect the volume, concentration and solubility of liquids that are stored for a long period of time in a plastic container. Containers filled with a liquid drug or with a liquid additive for a powdered drug desirably should have a relatively long shelf life. As a result, plastic containers are considered unacceptable for long term storage of liquid drugs or liquid additives for drugs.
- Glass is substantially impermeable to water and other liquids.
- liquid drugs or liquid additives for drugs typically are stored in glass tubes or other glass containers.
- glass is much more breakable than plastic.
- a glass tube can be broken easily while the tube is being manipulated to access the liquid stored therein.
- a small round glass tube can be dropped inadvertently and shattered inadvertently. Sharp edges of a broken glass tube can cut a patient or health care worker, and may create an open wound that can lead to disease transmission.
- Fragile glass containers also require protective packaging that typically increases storage space requirements and that may add to costs.
- the prior art has included attempts to minimize or offset the loss of liquid from plastic tubes. For example, one prior art attempt has bulk packaged a plurality of plastic tubes in a plastic tub. A moisture source also has been placed in the tub to provide a higher vapor content surrounding the bulk packaged tubes, and thereby to impede the outflow of liquid from the tubes. This prior art bulk packaging complicates the packaging process and adds to cost and storage space requirements. Furthermore, vapor from the moisture source is transported through the permeable walls of the plastic tub.
- the prior art also includes tubes that are laminated with foil to prevent liquid loss. Foil lamination of tubes adds significantly to the tube manufacturing complexity and adds to tube manufacturing cost.
- the subject invention is directed to a plastic container in which a liquid drug or a liquid additive solution for a drug has been placed.
- the plastic container may be formed from a known plastic material, such as polyethylene terephthalate (PET), polypropylene or other plastic material that exhibits liquid permeability.
- PET polyethylene terephthalate
- the container may be a tube of prior art construction, and may include a closed bottom, an open top and a continuous side wall extending therebetween.
- a closure may be securely mounted to the container for closing the open top, and thereby preventing spillage of the liquid drug or the liquid additive stored in the container.
- the subject invention further includes packaging formed from a high moisture barrier material that completely surrounds the container or that completely surrounds a plurality of such containers.
- the high moisture barrier material may be a film formed from a foil lamination, a metalized polyester, SiOx coated polyesters, polyester-polyoefilins, PVDC or the like.
- This high moisture barrier material may be a sheet folded around one or more plastic containers of a liquid drug or liquid additive. Edge regions of the sheet then may be sealed in face-to-face engagement with other areas on the sheet. Alternatively a container may be placed between two sheets of high moisture barrier material, and edge regions of the sheets may be sealed.
- the high moisture barrier packaging material can impede the rate of water vapor transport across the plastic material from which the container is formed by providing and maintaining a high relative humidity environment around the container and inside the package. This enables the volume, concentration and solubility of the liquid in the container to be controlled, and enables a longer shelf life for the liquid therein.
- FIG. 1 is a top plan view of a liquid-containing plastic tube packaged in accordance with the subject invention.
- FIG. 2 is a cross-sectional view taken along line 2-2 in FIG. 1.
- FIG.. 3 is a cross-sectional view similar to FIG. 2, but showing an alternate package.
- a package in accordance with the subject invention is identified generally by the numeral 10 in FIGS. 1 and 2.
- Package 10 contains a tube 12 formed from a plastic material, such as polyethylene terephthalate (PET) or polypropylene.
- Tube 12 includes a closed bottom 14 , an open top 16 , and a cylindrical side wall 18 extending therebetween.
- a liquid 20 is disposed in tube 12 as shown in FIG. 2.
- Liquid 20 may be a liquid additive of a specified volume, concentration and solubility that is intended for mixing with a non-liquid drug and for subsequent administration to a patient.
- liquid 20 may be a liquid drug.
- Closure 22 comprises a thermoplastic elastomer or a thermoset resin material that is sufficiently deformable and resilient for secure sealing engagement with side wall 18 of tube 12 .
- Closure 22 may further include a more rigid plastic structure to which the thermoplastic elastomer or thermoset resin is secured to enable closure 22 to be placed in and removed from tube 12 with ease.
- package 10 comprises a high moisture barrier film 26 that completely and relatively closely surrounds tube 12 .
- Film 26 may be a foil lamination comprising a substrate formed from a metallic foil, such as aluminum, and at least one layer formed from a plastic material that is readily sealable.
- the foil lamination may include an outer layer that is well suited to printing indicia to identify the specific liquid additive in tube 12 .
- Film 26 alternatively may be a metalized polyester, a SiOx coated polyester, a polyester-polyoefilin or PVDC, all of which are substantially impermeable to water, particularly in comparison to the PET or polypropylene from which tube 12 is formed.
- Film 26 of package 10 may define an envelope formed from a single sheet that is folded at fold region 28 to closely surround tube 12 . Adjacent registered edges 30 may be bonded in face-to-face relationship as shown in FIG. 2.
- package 10 may be formed from two separate sheets of film 26a and 26b as shown in FIG. 3. Sheets 26a and 26b may originally be in strip form. Tube 12 with liquid 20 therein may be placed on a lower sheet of film 26a , which may be part of a strip moving longitudinally along a conveying apparatus. Upper sheet of film 26b may be part of a second strip that is fed into juxtaposed relationship to the strip defining lower sheet of film 26a .
- the lower and upper sheets 26a and 26b may be sealed along opposed side edges 30a , and may subsequently be sealed and cut between adjacent tubes to form seals 32 .
- the lower and upper sheets of film 26a and 26b may be formed from different materials.
- a lower sheet of film 26a may be a foil lamination having an only upper layer of a plastic material that will bond well with a lower plastic layer on upper sheet 26b .
- Upper sheet 26b may also include an upper laminated layer that is well suited to receiving printed indicia.
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
A packaged liquid-filled plastic tube is provided to achieve a desirably long shelf life.
The tube is formed from PET, polypropylene or otherknown plastics that exhibit high liquid
permeability. A liquid additive of a specified volume, concentration and/or solubility is placed
in the tube and the tube is sealed. Loss of liquid through the permeable tube is prevented by a
moisture barrier film that is sealed around the tube. The moisture barrier film maintains a high
relative humidity adjacent said tube and substantially minimizes transport of liquid vapor
through the plastic of the tube.
Description
- This application is a non-provisional application of U.S. Provisional Patent Appl. No. 60/376,149 filed April 26, 2002.
- The subject invention relates to plastic tubes that have been prefilled with controlled volumes and concentrations of liquid, and that are packaged to retain the liquid volume and concentration during storage.
- Many medical procedures require a specified dose of a drug to be administered to a patient. Drugs that are administered intravenously must be in a liquid form. The liquid must be of known volume and concentration to ensure proper dosage.
- Some drugs can be stored for considerable periods of time in a liquid form. Other drugs, however, must be stored in a powdered form, and then must be mixed with a specified volume of a liquid additive shortly prior to administration to the patient. Efficiencies can be achieved if the specified volume of the liquid drug and/or the specified volume of the liquid additive is available in a prefilled tube or other such container. Prefilled containers avoid the need for careful volummetric measuring immediately prior to administering the drug, and hence minimize the chance for error.
- Plastic tubes and other plastic containers are lightweight, relatively inexpensive and relatively unbreakable. As a result, plastic tubes are used for medical applications whenever possible. However, plastic tubes have an inherent permeability to water and other liquids. This high liquid permeability of plastics can significantly affect the volume, concentration and solubility of liquids that are stored for a long period of time in a plastic container. Containers filled with a liquid drug or with a liquid additive for a powdered drug desirably should have a relatively long shelf life. As a result, plastic containers are considered unacceptable for long term storage of liquid drugs or liquid additives for drugs.
- Glass is substantially impermeable to water and other liquids. As a result, liquid drugs or liquid additives for drugs typically are stored in glass tubes or other glass containers. However, glass is much more breakable than plastic. A glass tube can be broken easily while the tube is being manipulated to access the liquid stored therein. Additionally, a small round glass tube can be dropped inadvertently and shattered inadvertently. Sharp edges of a broken glass tube can cut a patient or health care worker, and may create an open wound that can lead to disease transmission. Fragile glass containers also require protective packaging that typically increases storage space requirements and that may add to costs.
- The prior art has included attempts to minimize or offset the loss of liquid from plastic tubes. For example, one prior art attempt has bulk packaged a plurality of plastic tubes in a plastic tub. A moisture source also has been placed in the tub to provide a higher vapor content surrounding the bulk packaged tubes, and thereby to impede the outflow of liquid from the tubes. This prior art bulk packaging complicates the packaging process and adds to cost and storage space requirements. Furthermore, vapor from the moisture source is transported through the permeable walls of the plastic tub.
- The prior art also includes tubes that are laminated with foil to prevent liquid loss. Foil lamination of tubes adds significantly to the tube manufacturing complexity and adds to tube manufacturing cost.
- The subject invention is directed to a plastic container in which a liquid drug or a liquid additive solution for a drug has been placed. The plastic container may be formed from a known plastic material, such as polyethylene terephthalate (PET), polypropylene or other plastic material that exhibits liquid permeability. The container may be a tube of prior art construction, and may include a closed bottom, an open top and a continuous side wall extending therebetween. A closure may be securely mounted to the container for closing the open top, and thereby preventing spillage of the liquid drug or the liquid additive stored in the container.
- The subject invention further includes packaging formed from a high moisture barrier material that completely surrounds the container or that completely surrounds a plurality of such containers. The high moisture barrier material may be a film formed from a foil lamination, a metalized polyester, SiOx coated polyesters, polyester-polyoefilins, PVDC or the like. This high moisture barrier material may be a sheet folded around one or more plastic containers of a liquid drug or liquid additive. Edge regions of the sheet then may be sealed in face-to-face engagement with other areas on the sheet. Alternatively a container may be placed between two sheets of high moisture barrier material, and edge regions of the sheets may be sealed. The high moisture barrier packaging material can impede the rate of water vapor transport across the plastic material from which the container is formed by providing and maintaining a high relative humidity environment around the container and inside the package. This enables the volume, concentration and solubility of the liquid in the container to be controlled, and enables a longer shelf life for the liquid therein.
- FIG. 1 is a top plan view of a liquid-containing plastic tube packaged in accordance with the subject invention.
- FIG. 2 is a cross-sectional view taken along line 2-2 in FIG. 1.
- FIG.. 3 is a cross-sectional view similar to FIG. 2, but showing an alternate package.
- A package in accordance with the subject invention is identified generally by the numeral 10 in FIGS. 1 and 2.
Package 10 contains atube 12 formed from a plastic material, such as polyethylene terephthalate (PET) or polypropylene.Tube 12 includes a closed bottom 14, an open top 16, and acylindrical side wall 18 extending therebetween. A liquid 20 is disposed intube 12 as shown in FIG. 2.Liquid 20 may be a liquid additive of a specified volume, concentration and solubility that is intended for mixing with a non-liquid drug and for subsequent administration to a patient. Alternatively, liquid 20 may be a liquid drug. -
Liquid 20 is sealingly retained intube 12 by aclosure 22.Closure 22 comprises a thermoplastic elastomer or a thermoset resin material that is sufficiently deformable and resilient for secure sealing engagement withside wall 18 oftube 12.Closure 22 may further include a more rigid plastic structure to which the thermoplastic elastomer or thermoset resin is secured to enableclosure 22 to be placed in and removed fromtube 12 with ease. - The plastic material of
tube 12 is inherently permeable to water. Water vapor permeation through the plastic oftube 12 has the potential for affecting the volume, concentration or solubility ofliquid additive 20 stored intube 12. To substantially minimize vapor transport through the plastic oftube 12,package 10 comprises a highmoisture barrier film 26 that completely and relatively closely surroundstube 12.Film 26 may be a foil lamination comprising a substrate formed from a metallic foil, such as aluminum, and at least one layer formed from a plastic material that is readily sealable. The foil lamination may include an outer layer that is well suited to printing indicia to identify the specific liquid additive intube 12.Film 26 alternatively may be a metalized polyester, a SiOx coated polyester, a polyester-polyoefilin or PVDC, all of which are substantially impermeable to water, particularly in comparison to the PET or polypropylene from whichtube 12 is formed. -
Film 26 ofpackage 10 may define an envelope formed from a single sheet that is folded atfold region 28 to closely surroundtube 12. Adjacent registerededges 30 may be bonded in face-to-face relationship as shown in FIG. 2. Alternatively,package 10 may be formed from two separate sheets offilm Sheets Tube 12 withliquid 20 therein may be placed on a lower sheet offilm 26a, which may be part of a strip moving longitudinally along a conveying apparatus. Upper sheet offilm 26b may be part of a second strip that is fed into juxtaposed relationship to the strip defining lower sheet offilm 26a. The lower andupper sheets film film 26a may be a foil lamination having an only upper layer of a plastic material that will bond well with a lower plastic layer onupper sheet 26b.Upper sheet 26b, however, may also include an upper laminated layer that is well suited to receiving printed indicia.
Claims (11)
- Packaging for liquids of specified volume, concentration and solubility, said packaging comprising:at least one plastic container (12) having a closed bottom (14), an open top (16) and a side wall (18) extending therebetween, said liquid (20) of said specified volume, concentration and solubility being placed in said container (12), a closure (22) sealingly engaged with said open top of said container for retaining said liquid (20) therein, a moisture barrier film (26) completely surrounding said container (12) for preventing vapor transport across said film (26) and maintaining a selected relative humidity between said container (12) and said film (26) for substantially preventing permeation of said liquid (20) from said container (12).
- The packaging of Claim 1, wherein said container (12) is formed from polyethylene terephthalate or polypropylene.
- The packaging of Claims 1 or 2, wherein said film (26) is selected from the group consisting of foil laminations, metalized polyesters, SiOx coated polyesters, polyester-polyoefilins and PVDC.
- The packaging of any of Claims 1-3, comprising a single sheet of said film (26) folded around said container (12), registered edges of said sheet being secured to one another.
- The packaging of any of Claims 1-3, comprising first and second sheets of said film (26) having registered edges secured in face-to-face relationship with one another entirely around said container (12).
- A method for packaging liquids (20) to maintain a specified volume, concentration and solubility, said method comprising:providing a plastic container (12) having a closed bottom (14), an open top (16) and a side wall (18) extending therebetween;depositing in said plastic container (12) said liquid (20) of said specified volume, concentration and solubility;sealingly enganging a closure (22) with said open top (16) of said container (16) for retaining said liquid (20) therein;providing a moisture barrier film (26) completely around said plastic container (12) and said closure (22) for preventing vapor transport across said film (26) and maintaining a selected relative humidity between said container (12) and said film (26) for substantially preventing permeation of said liquid (20) from said container (12).
- The method of Claim 6, wherein said step of providing a container (12) comprises providing a container (12) formed from polyethylene terephthalate or polypropyelene.
- The method of Claims 6 or 7, wherein said step of providing a moisture barrier film (26) comprises providing a moisture barrier film (26) selected from the group consisting of foil laminations, metalized polyesters, SiOx coated polyesters, polyester-polyoefilins and PVDC.
- The method of any of Claims 6-8, wherein said step of completely surrounding said container (12) with a moisture barrier film (26) comprises folding a single sheet of said film (26) around said container (12) such that edges of said single sheet are substantially registered with one another and securing opposed faces of said sheet to one another adjacent said registered edges.
- The method of any of Claims 6-10, wherein said step of completely surrounding said container (12) with the moisture barrier film (26) comprises placing said container between first and second sheets of said moisture barrier film (26) and securing opposed faces of said first and second sheets to one another.
- The method of any of Claims 6-10, wherein said step of sealingly engaging a closure (22) with said open top (16) of said container (12) comprises providing a closure (22) formed from a thermoplastic elastomer or a thermoset resin and urging said closure (22) into said open top of said container (12) such that said closure (26) sealingly engages said side wall (18) of said container (12) adjacent said open top (16).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37614902P | 2002-04-26 | 2002-04-26 | |
US376149P | 2002-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1358938A1 true EP1358938A1 (en) | 2003-11-05 |
Family
ID=29215903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02023734A Withdrawn EP1358938A1 (en) | 2002-04-26 | 2002-10-23 | Collection assembly |
Country Status (2)
Country | Link |
---|---|
US (1) | US20030200727A1 (en) |
EP (1) | EP1358938A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2825237B1 (en) | 2012-03-15 | 2020-06-10 | Fisher & Paykel Healthcare Limited | Respiratory gas humidification system |
WO2013162386A1 (en) | 2012-04-27 | 2013-10-31 | Fisher & Paykel Healthcare Limited | Usability features for respiratory humidification system |
US11511069B2 (en) | 2013-09-13 | 2022-11-29 | Fisher & Paykel Healthcare Limited | Humidification system |
BR122017019820B1 (en) | 2013-09-13 | 2023-01-24 | Fisher & Paykel Healthcare Limited | CIRCUIT CONNECTOR FOR A HUMIDIFICATION SYSTEM AND CONDUIT FOR TRANSPORTING BREATHABLE GASES |
CN110947066B (en) | 2013-12-20 | 2023-07-18 | 费雪派克医疗保健有限公司 | Humidification system connection |
WO2015119515A1 (en) | 2014-02-07 | 2015-08-13 | Fisher & Paykel Healthcare Limited | Respiratory humidification system |
WO2015167347A1 (en) | 2014-05-02 | 2015-11-05 | Fisher & Paykel Healthcare Limited | Gas humidification arrangement |
EP4353290A3 (en) | 2014-05-13 | 2024-05-22 | Fisher & Paykel Healthcare Limited | Usability features for respiratory humidification system |
WO2015187039A1 (en) | 2014-06-03 | 2015-12-10 | Fisher & Paykel Healthcare Limited | Flow mixers for respiratory therapy systems |
WO2016080847A1 (en) | 2014-11-17 | 2016-05-26 | Fisher & Paykel Healthcare Limited | Humidification of respiratory gases |
WO2018106126A1 (en) | 2016-12-07 | 2018-06-14 | Fisher And Paykel Healthcare Limited | Sensing arrangements for medical devices |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4038148A (en) * | 1975-12-22 | 1977-07-26 | Marion Laboratories, Inc. | Anaerobic environmental system for bacteria culture testing |
EP0520443A2 (en) * | 1991-06-26 | 1992-12-30 | Ppg Industries, Inc. | Electrochemical sensor assembly |
EP0787823A2 (en) * | 1996-01-30 | 1997-08-06 | Becton, Dickinson and Company | Blood collection tube assembly |
WO1999022691A1 (en) * | 1997-10-31 | 1999-05-14 | Abbott Laboratories | System for storing oxygen sensitive compositions |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2283867A (en) * | 1939-12-19 | 1942-05-19 | Stokes Machine Co | Packaging and preserving dried biologicals, pharmaceuticals, and the like |
US4108309A (en) * | 1976-10-15 | 1978-08-22 | All One God Faith, Inc. | Contraceptive containing device |
US4927010A (en) * | 1988-12-27 | 1990-05-22 | Sealed Air Corporation | Shipping bag for containers of potentially biohazardous liquids |
US4942966A (en) * | 1989-06-05 | 1990-07-24 | Kemp David R | Containment device for a test tube |
GB9411626D0 (en) * | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Package |
US5647480A (en) * | 1995-01-27 | 1997-07-15 | Minnesota Mining And Manufacturing Company | Flexible pressure vessels for and method of transporting hazardous materials |
WO1998045191A1 (en) * | 1997-04-10 | 1998-10-15 | Johns Hopkins University | Gaz syringe and package therefor |
US6119853A (en) * | 1998-12-18 | 2000-09-19 | Glaxo Wellcome Inc. | Method and package for storing a pressurized container containing a drug |
US6161687A (en) * | 1999-02-10 | 2000-12-19 | Technicor, Inc. | Vial container |
US6308827B1 (en) * | 1999-02-10 | 2001-10-30 | Technicor Inc. | Labeling system for vial container |
-
2002
- 2002-10-11 US US10/271,107 patent/US20030200727A1/en not_active Abandoned
- 2002-10-23 EP EP02023734A patent/EP1358938A1/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4038148A (en) * | 1975-12-22 | 1977-07-26 | Marion Laboratories, Inc. | Anaerobic environmental system for bacteria culture testing |
EP0520443A2 (en) * | 1991-06-26 | 1992-12-30 | Ppg Industries, Inc. | Electrochemical sensor assembly |
EP0787823A2 (en) * | 1996-01-30 | 1997-08-06 | Becton, Dickinson and Company | Blood collection tube assembly |
WO1999022691A1 (en) * | 1997-10-31 | 1999-05-14 | Abbott Laboratories | System for storing oxygen sensitive compositions |
Also Published As
Publication number | Publication date |
---|---|
US20030200727A1 (en) | 2003-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11452811B2 (en) | Application arrangement with a medicinal substance fluid | |
EP1520574B1 (en) | Flexible medical container packaging | |
EP0639364B1 (en) | Container having a plurality of chambers | |
ES2434940T3 (en) | Flexible container and manufacturing method | |
US20170008686A1 (en) | Packaged medicine-filled container | |
JP2007020710A (en) | Medical container packing body | |
EP1358938A1 (en) | Collection assembly | |
JPH03501443A (en) | Flexible containers for cell culture media | |
JP7112756B2 (en) | prepackaged medical devices | |
CN101641071A (en) | Multi-compartment package | |
CA1192867A (en) | Bags for medical use and intended in particular for parenteral nutrition | |
CN101564350A (en) | Soft package of instantaneous matching type medical inner bag with a plurality of chambers | |
CN212922712U (en) | Combined package | |
US20040118859A1 (en) | Fluid container pouch | |
JPH0639713Y2 (en) | Infusion bag | |
JP4335334B2 (en) | Drug infusion container | |
CN201194919Y (en) | Instant matched medical multi-chamber internal-bag flexible package | |
JP4385689B2 (en) | Laminate with suppressed generation of pinholes and infusion bag package using the laminate | |
JP2008132100A (en) | Packaging bag for liquid bag and liquid bag package | |
JPS6278061A (en) | Packaging bag | |
JPH0652832U (en) | Packaging bag and package for chemical solution filling bag | |
JP2005096792A (en) | Laminated packaging material and laminated packaging bag, which suppress formation of pinhole | |
JP2003267451A (en) | Barrier film and container to which barrier film is applied | |
JPH0120284Y2 (en) | ||
JPH07116306B2 (en) | Medical liquid packaging material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
17P | Request for examination filed |
Effective date: 20040408 |
|
AKX | Designation fees paid |
Designated state(s): DE FR |
|
17Q | First examination report despatched |
Effective date: 20050621 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20051102 |